SE8701479L - METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF - Google Patents

METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF

Info

Publication number
SE8701479L
SE8701479L SE8701479A SE8701479A SE8701479L SE 8701479 L SE8701479 L SE 8701479L SE 8701479 A SE8701479 A SE 8701479A SE 8701479 A SE8701479 A SE 8701479A SE 8701479 L SE8701479 L SE 8701479L
Authority
SE
Sweden
Prior art keywords
biologically effective
containing biologically
effective preparations
active substance
biologically active
Prior art date
Application number
SE8701479A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8701479D0 (en
Inventor
U Schroeder
Original Assignee
Carbomatrix Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbomatrix Ab filed Critical Carbomatrix Ab
Priority to SE8701479A priority Critical patent/SE8701479L/en
Publication of SE8701479D0 publication Critical patent/SE8701479D0/en
Priority to PCT/SE1988/000183 priority patent/WO1988007870A1/en
Publication of SE8701479L publication Critical patent/SE8701479L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A pharmaceutical formulation is described, which is made of a prefabricated microspher/particle, combined with a pharmaceutically acceptable polymer which delays the release of the entrapped biologically active substance. Also described is the use of the formulation for the biologically active substance.
SE8701479A 1987-04-09 1987-04-09 METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF SE8701479L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE8701479A SE8701479L (en) 1987-04-09 1987-04-09 METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF
PCT/SE1988/000183 WO1988007870A1 (en) 1987-04-09 1988-04-11 A method for entrapment of biologically active substances and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701479A SE8701479L (en) 1987-04-09 1987-04-09 METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF

Publications (2)

Publication Number Publication Date
SE8701479D0 SE8701479D0 (en) 1987-04-09
SE8701479L true SE8701479L (en) 1988-10-10

Family

ID=20368147

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701479A SE8701479L (en) 1987-04-09 1987-04-09 METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF

Country Status (2)

Country Link
SE (1) SE8701479L (en)
WO (1) WO1988007870A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244147A (en) † 1991-09-03 1994-09-27 Hoechst Ag Echogenic particles which comprise a gas and at least one shaping substance, and their use as diagnostic agents
DE69220317T2 (en) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Microparticle summary for extended release and manufacture of the same
DK0744940T3 (en) * 1994-02-17 1999-07-26 Pankaj Modi Medications, vaccines and hormones in polylactide-coated microspheres
KR100201352B1 (en) * 1995-03-16 1999-06-15 성재갑 Single shot vaccine formulation
SE505146C2 (en) * 1995-10-19 1997-06-30 Biogram Ab Particles for delayed release
WO1998029141A1 (en) 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
FR2778336A1 (en) * 1998-05-11 1999-11-12 Jean Pierre Perraud Injectable bioabsorbable implant for filling in wrinkles, cutaneous depressions and parodontal pockets
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US8524279B2 (en) 2001-11-01 2013-09-03 Novartis Ag Spray drying methods and related compositions
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP3450559A1 (en) 2003-03-07 2019-03-06 Alnylam Pharmaceuticals, Inc. Therapeutic compositions
ES2702942T3 (en) 2003-04-17 2019-03-06 Alnylam Pharmaceuticals Inc Modified RNAi agents
CA2522349A1 (en) 2003-04-17 2004-11-04 Alnylam Pharmaceuticals, Inc. Protected monomers
CA3043911A1 (en) 2007-12-04 2009-07-02 Arbutus Biopharma Corporation Targeting lipids
AU2009234266B2 (en) 2008-04-11 2015-08-06 Tekmira Pharmaceuticals Corporation Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
WO2011109427A2 (en) 2010-03-01 2011-09-09 Alnylam Pharmaceuticals, Inc. Improving the biological activity of sirna through modulation of its thermodynamic profile
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE640616A (en) * 1962-12-19
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
SE8204244L (en) * 1982-07-09 1984-01-10 Ulf Schroder Crystallized Carbohydrate Matrix for BIOLOGICALLY ACTIVE SUBSTANCES
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
FR2557459B1 (en) * 1984-01-02 1986-05-30 Lhd Lab Hygiene Dietetique POLYCAPROLACTONE-BASED INERT MATRIX FOR ORAL ADMINISTRATION OF A MEDICAMENT, AND METHOD FOR PREPARING THE GALENIC FORM COMPRISING THE SAME

Also Published As

Publication number Publication date
WO1988007870A1 (en) 1988-10-20
SE8701479D0 (en) 1987-04-09

Similar Documents

Publication Publication Date Title
SE8701479L (en) METHOD FOR CONTAINING BIOLOGICALLY EFFECTIVE PREPARATIONS AND USE THEREOF
ATE68343T1 (en) CONTROLLED RELEASE PHARMACEUTICAL FORM.
NO891052D0 (en) PHARMACEUTICAL PRODUCT FOR CONTROLLED RELEASE.
NO904754D0 (en) Capsule for encapsulation of biologically active materials, method of preparation thereof, and use thereof.
DE3868037D1 (en) PHARMACEUTICAL COMPOSITION WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE.
DE69013473D1 (en) Medicines containing cimetidine.
SE8504720L (en) NEW PHARMACEUTICAL PREPARATION
NO884154L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PREPARATIONS.
DK196189D0 (en) ORAL OSMOTIC DISPENSING SYSTEM CONTAINING A PHARMACOLOGICAL ACTIVE SUBSTANCE
NO863670D0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION OF A HYDROPHOBIC MEDICINE.
DE68928034D1 (en) PROTEIN WITH TIME ADMINISTRATION
NO892826D0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR AA PREVENT SEXUALLY TRANSFERABLE DISEASES.
DE58901990D1 (en) SOLID PHARMACEUTICAL RETARD FORM.
NO882406D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE URINE AND CARBAMATE COMPOUNDS.
NO942303D0 (en) Pharmaceutical composition and method of preparation thereof
DE68905613D1 (en) PHARMACEUTICAL PREPARATION.
NO921603D0 (en) PROCEDURE FOR THE PREPARATION OF AN ACTIVE FINDING AGENT FOR USE FOR CONCRETE
NO892871D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO933237D0 (en) Absorbate of an excipient mixture and a non-solid active substance for the manufacture of pharmaceutical preparations
NO904470D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZODIAZEPINE DERIVATIVES.
NO173098C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 10-PROPYNOL ANDROSTENES
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
NO891678L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ETHANOLAMINE DERIVATIVES.
NO890502D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ETHANOLAMINE DERIVATIVES.
AU2791295A (en) Method of determining the amount of active substance released from solid or semi-solid preparations administered to humans or animals

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701479-1

Effective date: 19881216